Clinical Trials at NYC Research
During the past decade, NYC Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NYC Research
According to Clinical.Site data, the most researched conditions in "NYC Research" are
"Diabetes" (1 trials), "Type 1 Diabetes" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "NYC Research" in a lesser frequency.
Clinical Trials Intervention Types at NYC Research
Most popular intervention types in "NYC Research" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Insulin Degludec" (2 trials) and "Insulin Efsitora Alfa" (2 trials). Other intervention names were less common.
Clinical Trials Genders at NYC Research
The vast majority of trials in "NYC Research" are
2 trials for "All" genders.
Clinical Trials Status at NYC Research
Currently, there are NaN active trials in "NYC Research".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in NYC Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NYC Research, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".